| Shareholder | |||
|---|---|---|---|
| Frank WuExecutive Director | 25.87% | 80.90M | |
| Shanghai Guoxin Investment Development Co., Ltd. | 8.73% | 8.31M | |
| 國投創業投資管理有限公司 | 6.93% | 21.68M | |
| CS Capital Co., Ltd.(国投招商投资管理有限公司) | 5.85% | 18.29M | |
| Ghalibo (PTC) Limited | 5.76% | 18.02M | |
| Chan Tan Ching Fen | 5.76% | 18.02M | |
| China Structural Reform Fund Corporation Limited | 5.35% | 16.14M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| Chan Tan Ching Fen | -1.00M | 10.59 | Sold | 18.02M | 5.76% | ||
| Ghalibo (PTC) Limited | -1.00M | 10.59 | Sold | 18.02M | 5.76% | ||
| Morningside Holdings (Asia) Limited | -1.00M | 10.59 | Sold | 18.02M | 5.76% | ||
| Morningside Bio-Ventures Limited | -1.00M | 10.59 | Sold | 18.02M | 5.76% | ||
| Morningside Venture (I) Investments Limited | -1.00M | 10.59 | Sold | 18.02M | 5.76% | ||
| Genecare Development Limited | -1.00M | 10.59 | Sold | 18.02M | 5.76% | ||
| CS Capital Co., Ltd.(国投招商投资管理有限公司) | -1.77M | 13.74 | Sold | 18.29M | 5.85% | ||
| Future Industry Investment Fund II (Limited Partnership) (先进制造产业投资基金二期 (有限合伙)) | -1.77M | 13.74 | Sold | 18.29M | 5.85% | ||
| Chan Tan Ching Fen | -467.50K | 12.58 | Sold | 21.49M | 6.87% | ||
| Ghalibo (PTC) Limited | -467.50K | 12.58 | Sold | 21.49M | 6.87% | ||
| Morningside Holdings (Asia) Limited | -467.50K | 12.58 | Sold | 21.49M | 6.87% | ||
| Morningside Bio-Ventures Limited | -467.50K | 12.58 | Sold | 21.49M | 6.87% | ||
| Morningside Venture (I) Investments Limited | -467.50K | 12.58 | Sold | 21.49M | 6.87% | ||
| Genecare Development Limited | -467.50K | 12.58 | Sold | 21.49M | 6.87% | ||
| Chan Tan Ching Fen | -226.50K | 11.07 | Sold | 24.83M | 7.94% | ||
| Ghalibo (PTC) Limited | -226.50K | 11.07 | Sold | 24.83M | 7.94% | ||
| Morningside Holdings (Asia) Limited | -226.50K | 11.07 | Sold | 24.83M | 7.94% | ||
| Morningside Bio-Ventures Limited | -226.50K | 11.07 | Sold | 24.83M | 7.94% | ||
| Morningside Venture (I) Investments Limited | -226.50K | 11.07 | Sold | 24.83M | 7.94% | ||
| Genecare Development Limited | -226.50K | 11.07 | Sold | 24.83M | 7.94% | ||
| Future Industry Investment Fund II (Limited Partnership) (先进制造产业投资基金二期 (有限合伙)) | -3.85M | 13.26 | Sold | 20.37M | 6.51% | ||
| CS Capital Co., Ltd.(国投招商投资管理有限公司) | -3.85M | 13.26 | Sold | 20.37M | 6.51% | ||
| 南京药石科技股份有限公司 | -10.33M | 12.21 | Sold | 11.78M | 3.77% | ||
| 上海金浦醫療健康股權投資基金管理有限公司 | -4.78M | 12.50 | Sold | 12.37M | 3.96% |
This page shows the major shareholders of TRANSTHERA-B (02617) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

